Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4643305
Max Phase: Preclinical
Molecular Formula: C21H28N7O7P
Molecular Weight: 521.47
Molecule Type: Unknown
Associated Items:
ID: ALA4643305
Max Phase: Preclinical
Molecular Formula: C21H28N7O7P
Molecular Weight: 521.47
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)[C@H](C)NP(=O)(NC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@](C)(O)[C@@H]1O)Oc1ccccc1
Standard InChI: InChI=1S/C21H28N7O7P/c1-12(19(30)33-3)27-36(32,35-13-7-5-4-6-8-13)26-9-14-16(29)21(2,31)20(34-14)28-11-25-15-17(22)23-10-24-18(15)28/h4-8,10-12,14,16,20,29,31H,9H2,1-3H3,(H2,22,23,24)(H2,26,27,32)/t12-,14+,16+,20+,21+,36?/m0/s1
Standard InChI Key: RPXSLSGSUOXTIA-ZBJOKRQFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 521.47 | Molecular Weight (Monoisotopic): 521.1788 | AlogP: 0.35 | #Rotatable Bonds: 9 |
Polar Surface Area: 195.97 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.22 | CX Basic pKa: 4.92 | CX LogP: -0.79 | CX LogD: -0.79 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.19 | Np Likeness Score: 0.53 |
1. Procházková E, Hřebabecký H, Dejmek M, Šála M, Šmídková M, Tloušťová E, Zborníková E, Eyer L, Růžek D, Nencka R.. (2020) Could 5'-N and S ProTide analogues work as prodrugs of antiviral agents?, 30 (4): [PMID:31882298] [10.1016/j.bmcl.2019.126897] |
Source(1):